Endothelin antagonists: N-((2'-(((4,5-Dimethyl-3-isoxazolyl) amino)sulfonyl)-4-(2-oxazolyl) (11'-biphenyl)-2-yl]methyl] N,3,3-trimethylbutanamide and N-(4,5-Dimethyl-3-isoxazolyl) 2'-((3,3-Dimethyl-2-oxo-1-pyrrolidinyl) methyl)-4' (2-oxazolyl)(1,1'-Biphen
A Standard patent application filed on 26 January 1998 credited to Murugesan, Natesan
;
Morrison, Richard A.
;
Gu, Zhengxiang
;
Barrish, Joel C.